Non-Alcoholic Fatty Liver Disease and its Interplay with Various Metabolic Disorders

 

Abstract

Nonalcoholic fatty liver disease (NAFLD) is described as exposition of multiplex liver metabolic disturbance interconnected with obesity. NAFLD is depicted by steatosis, excessive accumulation of fats in liver, due to triglycerides export and oxidation of fatty acid from plasma and de novo synthesis. Hepatic steatosis can therefore be explained as biochemical outcome of inconsistency between interfused mechanisms of lipid biotransformation. This condition is allied to a range of various modifications in lipoproteins, fatty acids, and glucose metabolisms in organism. So, above metabolic disfunctions are suspected to be the origin of possibility for adverse cardiometabolic risk agents related to NAFLD, like dyslipidemia, Type 2 diabetes mellitus (T2DM), and insulin resistance. Reactive oxygen species (ROS) generation participates as known inducer of inflammation and oxidative stress, that exacerbate this disease. These disorders are hallmarks that worsen NAFLD complications, so far participate in developing advanced stages of NAFLD and incline the body to CVD and T2D. The reciprocal risks exist among these diseases. Given the sharp growing prevalence and persistence of NAFLD, and its complexity that provoke additional metabolic syndrome, this review discusses various mechanisms of developing NAFLD, interaction with other associated hallmarks, aiming to clarify beneficial mechanisms for improvement.

 

 Read more about this article: https://lupinepublishers.com/gastroenterology-hepatology-journal/fulltext/non-alcoholic-fatty-liver-disease-and-its-interplay-with-various-metabolic-disorders.ID.000151.php

Read about Lupine Publishers Google Scholar Articles:  https://scholar.google.com/citations?view_op=view_citation&hl=en&user=2Ob8GqcAAAAJ&cstart=20&pagesize=80&citation_for_view=2Ob8GqcAAAAJ:yTLRzDEmwhEC

Comments

Popular posts from this blog

The Use of Sodium-Glucose Cotransporter 2 Inhibitors in Non-Alcoholic Fatty Liver Disease

Acute Upper Gastrointestinal Bleeding (UGIB) In A Resource Limited Setting Highly Endemic for Viral Hepatitis B: Which Etiologies for Which Real Clinical Practices?

Food Sources and Bioavailability of Calcium